(PRWEB) March 6, 2006
A wealth of market, company and product intelligence on this dynamically-changing industry sector - includes market forecasts to 2010.
The Changing Corporate Face of Generics
Sandoz/Hexal, Teva/IVAX, Actavis/Alpharma – who next? On the back of significant growth in both turnover and profits, generic companies are flexing their financial muscle in strategic acquisitions in order to increase market share and defend profit margins.
US Market Under Pressure?
Companies in the world’s largest generic market, the US, are feeling the chill wind of competition and price pressure. Against a background of troubling financial results, companies in the US are bracing themselves for tough trading. While new generic opportunities continue to emerge, pressure from drug purchasers to keep prices low, the unknown influence of the Medicare drug benefit in 2006 and the negative impact of shared market exclusivity periods are unsettling the marketplace.
Key Company, Market and Product Information
Packed with facts, figures and statistics, the 400+ page report provides the most thorough report available on generic markets, products and companies and the issues they face.
Industry Consolidation, Pressure on Prices, Biogenerics
Published in December 2005, this report draws on primary research with companies, statistics offices, health ministries and trade associations worldwide and provides standard, comparative data and discussion on key issues such as:
- The trend in corporate consolidation
- The trend to greater generic substitution
- Biogenerics: regulatory & technical issues
- US generic pricing pressures
- Key legal challenges
- The political and funding background
- Intellectual property issues
“World Generic Markets Report 2006: 4th Edition” is priced at £495 and is available in hard copy and PDF format from Piribo. For more information, go to: http://www.piribo.com/publications/generic_drugs/world_market_2006
Piribo is a UK-based independent online store supplying business information on the pharmaceutical and biotechnology industries. The website now carries over 3,000 English language titles including, market reports, studies and books and is the UK’s largest online biopharma information store. Subscribers receive a free monthly newsletter and email alerts on new titles in their areas of interest. The company was established in 2004.